Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralymphatic allergen immunotherapy for seasonal allergic rhinitis
2009-016815-39Phase 2Completed
- Sponsor
- Department of Otorhinolaryngology, Lund University
- Start
- Nov 2009
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of alutard-sq and ALK Alutard 5-grasses in seasonal allergic rhinitis (SAR) (3 arms), sponsored by Department of Otorhinolaryngology, Lund University. Primary endpoint: Comparative primary analysis. Started Nov 2009; status: completed.
02
Drugs
alutard-sqALK Alutard 5-grasses
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2009-016815-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016815-39.